Meta-analysis of association between matrix metalloproteinases 2, 7 and 9 promoter polymorphisms and cancer risk

Bin Peng(Shenzhen University Health Science Center), Lei Yu(Taiyuan Central Hospital), D. Wang(China-Japan Friendship Hospital), Lihuan Cao(Fudan University), Xiaolu Ma(Fudan University), W. Wang(Fudan University)
Mutagenesis
April 1, 2010
10.1093/mutage/geq015
Cited by 65

Related Papers

Plasma MicroRNA Panel to Diagnose Hepatitis B Virus–Related Hepatocellular Carcinoma
|Journal of Clinical Oncology|2011|644
Adjuvant Transarterial Chemoembolization for HBV-Related Hepatocellular Carcinoma After Resection: A Randomized Controlled Study
|Clinical Cancer Research|2018|355
<i>IDH</i> mutations predict longer survival and response to temozolomide in secondary glioblastoma
|Cancer Science|2011|296
WormBase 2012: more genomes, more data, new website
|Nucleic Acids Research|2011|187
Acquired temozolomide resistance in MGMT-deficient glioblastoma cells is associated with regulation of DNA repair by DHC2
|Brain|2019|186